Cardiac Disease in Athletes




The Athlete’s Heart


Definition


Intense regular physical exercise can induce physiologic and morphologic cardiac changes known as “athlete’s heart”. These adaptations are considered a normal response to repetitive exercise training.


Physiologic Changes





  • Increased vagal tone



  • Morphologic changes, including left ventricular (LV) enlargement, increases in LV wall thickness, and increases in LV mass



Pathologic vs. Physiologic Hypertrophy





  • The physiologic changes that occur in response to training can be difficult to differentiate from the pathologic processes that occur in hypertrophic cardiomyopathy (HCM) ( Table 35.1 ).



    TABLE 35.1

    DISTINGUISHING HCM FROM ATHLETE’S HEART


































    HCM Athlete’s Heart
    Unusual pattern of LVH, may be heterogeneous Symmetric LVH or uniform distribution of hypertrophy
    Wall thickness > 16 mm Wall thickness < 12 mm
    LV cavity < 45 mm (small) LV cavity > 55 mm (not small)
    Left atrial enlargement No left atrial enlargement
    Abnormal LV filling Normal LV filling
    EKG abnormalities (see Chapter 30 ) EKG with high voltage, but no Q wave changes (see Chapter 30 )
    Thickness does not decrease with deconditioning LVH decreases with deconditioning
    Family history of HCM No family history of HCM
    Positive genetic testing for HCM Negative genetic testing for HCM



  • Magnetic resonance imaging (MRI) can detect atypical patterns of hypertrophy and late gadolinium enhancement, which may be suggestive of HCM.



  • If the distinction between pathologic and physiologic hypertrophy cannot be established, a period of deconditioning should be considered.



Participation Recommendations





  • Athlete’s heart describes normal physiologic adaptations to regular intense exercise, and thus, no treatment and no limits on sports participation are required.





Sudden Cardiac Death


Epidemiology





  • Sudden cardiac death (SCD) is the leading medical cause of death in young athletes.



  • The actual incidence of SCD in athletes is difficult to estimate because of the lack of a mandatory national reporting system.



  • New research suggest the incidence of SCD is around 1 in 50,000 athlete-years (AY) in college athletes and 1 in 80,000 AY in high school athletes with some higher-risk populations ( Table 35.2 ).



    TABLE 35.2

    INCIDENCE OF SUDDEN CARDIAC DEATH AND ARREST IN ATHLETES





























































































































































    Author Year Country Method Population Incidence * Number of Years Age Range (Years)
    Boden 2013 US Retrospective cohort College/high school football 1 : 112,359 college
    1: 312,500 high school
    Van Camp 1996 US Retrospective cohort College/high school athletes 1 : 300,000 10 17–24
    Maron 2009 US Retrospective cohort Athletes 1 : 163,934 27 8–39
    Steinville 2011 Israel Retrospective cohort Athletes 1st – 1 : 39,370
    2 nd – 1 : 37,593
    24 12–44
    Corrado 2003 Italy Prospective cohort study Athletes/young people 1 : 47,600 athlete
    1 : 142,900 young people
    20 12–35
    Holst 2010 Denmark Retrospective cohort Athletes/young people 1 : 82,645 athlete
    1 : 26,595 general pop
    7 12–35
    Drezner 2005 US Retrospective cohort College athletes 1 : 67,000 3.3
    Harmon 2011 US Retrospective cohort College athletes 1 : 43,000 5 18–26
    Harmon 2015 US Retrospective cohort College athletes 1 : 53,000 10 17–26
    Maron 2014 US Retrospective cohort College athletes 1 : 83,000 – confirmed
    1 : 62,000 – presumed
    10 17–26
    Drezner 2009 US Cross-sectional survey High school athletes 1 : 23,000 SCA + SCD
    1 : 46,000 SCD
    Toresdahl 2014 US Prospective observational High school athletes 1 : 87,719 SCA + SCD 3 14–18
    Maron 2012 US Retrospective cohort High school athletes 1 : 150,000 26 12–18
    Roberts 2013 US Retrospective cohort High school athletes 1 : 416,666 last decade
    1 : 917,000
    Maron 1998 US Retrospective cohort High school athletes 1 : 217,000 overall 11
    Marjion 2011 France Prospective Competitive athletes 1 : 102,00 10–35

    * Incidence numbers are in athlete-years.




  • Males and African Americans are at a higher risk, with men’s basketball appearing to be at a disproportionately higher risk: 1 in 9,000 AY.



Presentation





  • The prevalence of cardiovascular disorders in young people that can potentially lead to SCD is approximately 1 in 300.



  • Most individuals with cardiovascular disorders will not go on to experience sudden cardiac arrest (SCA) or SCD; however, athletes may be at a higher risk because of their increased level of physical activity, which can be a trigger for arrhythmias.



  • SCD is the presenting symptom of underlying cardiovascular pathology in 50%–90% of athletes limiting the usefulness of a history-based screen.



  • Warning symptoms of underlying cardiovascular disease include a history of exertional chest pain, exertional syncope or presyncope, dyspnea or fatigue disproportionate to the degree of exertion, and palpitations or irregular heartbeats. Athletes with any of these symptoms require a careful workup before returning to exercise.



  • A family history of sudden unexplained death or SCD before the age of 50 years or a history of familial cardiac disorders known to cause SCD in young athletes also warrant further diagnostic investigation before participation.



Etiology of SCD in Athletes





  • Older studies in US athletes suggest HCM as the leading cause of SCD in athletes; however, more recent studies and studies in the US military suggest that a pathologically normal heart is the most common finding at autopsy.



  • Studies in other countries and a recent meta-analysis also suggest HCM may be less common as a cause of SCD than previously thought ( Table 35.3 ).



    TABLE 35.3

    STUDIES OF THE ETIOLOGIES OF SUDDEN CARDIAC DEATH IN YOUNG PEOPLE


































































































































    Author Year Country Exertional Death vs. All Deaths Population Age Range (Years) Number of Deaths HCM Idiopathic LVH/ Possible HCM Coronary Artery Abnormalities ARVC DCM AN-SUD CAD Myocarditis Related Aortic Dissection Other
    Corrado 2003 Italy all Competitive athletes 12–35 55 2% 0% 13% 22% 0% 7% 20% 13% 2% 22%
    De Noronha 2009 UK all Athletes 1–35 89 12% 25% 8% 10% 0% 19% 8% 3% 0% 4%
    Maron 2009 US all Athletes 8–39 690 36% 8% 17% 4% 2% 3% 6% 3% 20%
    Holst 2010 Denmark exertional Competitive
    athletes
    12–35 15 0% 7% 7% 27% 0% 27% 13% 7% 0% 13%
    Suarez-Mier 2011 Spain exertional Recreational athletes 9–35 81 10% 9% 6% 15% % 23% 14% 5% 0% 19%
    Harmon 2014 US all Competitive athletes 18–26 36 3% 8% 14% 3% 8% 32% 5% 8% 8% 5%

    Only gold members can continue reading. Log In or Register to continue

    Stay updated, free articles. Join our Telegram channel

Jul 19, 2019 | Posted by in SPORT MEDICINE | Comments Off on Cardiac Disease in Athletes

Full access? Get Clinical Tree

Get Clinical Tree app for offline access